BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIVI BioVie Inc

盘后交易 08-20 17:28:21 EDT

1.86

+0.52

+38.81%

盘后1.92

+0.06+3.23%

17:28 EDT

最高2.39	最低1.49	成交量4,862万
今开1.55	昨收1.34	日振幅67.16%
总市值1,391万	流通市值1,384万	总股本747.71万
成交额9,340万	换手率653.24%	流通股本744.33万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIVI","market":"US","secType":"STK","nameCN":"BioVie Inc","latestPrice":1.86,"timestamp":1787256000000,"preClose":1.34,"halted":0,"volume":48622795,"hourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.86,"latestTime":"17:28 EDT","volume":501666,"amount":974228.4991758,"timestamp":1787261291720,"change":0.06,"changeRate":0.032258,"amplitude":0.182527},"delay":0,"changeRate":0.3880597014925373,"floatShares":7443300,"shares":7477100,"eps":-3.049999,"marketStatus":"盘后交易","change":0.52,"latestTime":"08-20 17:28:21 EDT","open":1.545,"high":2.39,"low":1.4901,"amount":93404802.48875749,"amplitude":0.671567,"askPrice":1.97,"askSize":2000,"bidPrice":1.91,"bidSize":29,"shortable":3,"etf":0,"ttmEps":-3.049999,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787270400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.34,"preHourTrading":{"tag":"盘前","latestPrice":1.5498,"preClose":1.34,"latestTime":"09:29 EDT","volume":1175817,"amount":1808900.7418851,"timestamp":1787232589789,"change":0.2098,"changeRate":0.156567,"amplitude":0.231343},"postHourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.86,"latestTime":"17:28 EDT","volume":501666,"amount":974228.4991758,"timestamp":1787261291720,"change":0.06,"changeRate":0.032258,"amplitude":0.182527},"volumeRatio":3.873224,"impliedVol":1.6378,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BIVI","defaultTab":"news","newsList":[{"id":"1122397032","title":"BioVie Inc.旗下Bezisterim在运动与非运动症状改善方面展现显著统计优势，远超安慰剂组","url":"https://stock-news.laohu8.com/highlight/detail?id=1122397032","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122397032?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:33","pubTimestamp":1786016032,"startTime":"0","endTime":"0","summary":"BioVie Inc.宣布，其候选药物Bezisterim在临床试验中取得了突破性成果。与安慰剂对照组相比，该药物在改善患者运动及非运动症状方面，均展现出具有统计学意义的显著提升。这一发现，无疑为神经退行性疾病领域注入了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117468692","title":"BioVie二期试验达成预设终点：Bezisterim显著改善炎症与生物标志物","url":"https://stock-news.laohu8.com/highlight/detail?id=1117468692","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117468692?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:31","pubTimestamp":1786015883,"startTime":"0","endTime":"0","summary":"BioVie公司宣布，其二期临床试验成功达成预设终点。在本次试验中，候选药物Bezisterim展现出改善炎症指标及生物标志物的潜力。这一结果，无疑为后续研发工作注入了一剂强心针。试验数据表明，该药物在调整特定生物标记物水平方面表现积极，从而为炎症相关疾病的治疗策略提供了新的可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135112588","title":"BioVie Inc公布Bezisterim早期帕金森病2期Sunrise-Pd试验顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1135112588","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135112588?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:31","pubTimestamp":1786015882,"startTime":"0","endTime":"0","summary":"BioVie Inc近日宣布，其针对早期帕金森病（Parkinson's Disease）的候选药物Bezisterim，在名为Sunrise-Pd的2期临床试验中，取得了关键性顶线研究成果。这一消息引发了市场与医学界的广泛关注，为神经退行性疾病治疗领域注入了新的期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182736240","title":"BioVie宣布完成Bezisterim治疗长新冠相关神经症状的Address-Lc试验患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1182736240","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182736240?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:01","pubTimestamp":1779796880,"startTime":"0","endTime":"0","summary":"BioVie公司宣布，其针对Bezisterim治疗长新冠病毒感染相关神经症状的Address-Lc临床试验，现已完成全部患者的入组工作。该试验旨在评估候选药物对长新冠患者神经系统后遗症的潜在疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614156518","title":"Biovie Inc.盘中异动 急速拉升6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614156518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614156518?lang=zh_cn&edition=full","pubTime":"2026-02-28 01:04","pubTimestamp":1772211887,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日01时04分，Biovie Inc.股票出现波动，股价急速上涨6.30%。截至发稿，该股报1.35美元/股，成交量4.6729万股，换手率0.62%，振幅6.30%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Biovie Inc.公司简介：BioVie Inc是一家临床阶段的公司，开发药物治疗慢性衰弱性疾病，包括肝病、神经和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228010447a727948e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260228010447a727948e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518224716","title":"Biovie Inc.盘中异动 早盘大幅跳水5.04%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518224716?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Biovie Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报1.13美元/股，成交量4646股，换手率0.03%，振幅0.00%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a242f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213103a26a242f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516765199","title":"Biovie Inc.盘中异动 股价大跌5.26%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516765199?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:57","pubTimestamp":1741024634,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时57分，Biovie Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报1.26美元/股，成交量9.4581万股，换手率0.51%，振幅4.50%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304015715a25d7c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304015715a25d7c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331748","title":"Biovie Inc.盘中异动 股价大跌5.59%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331748?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:35","pubTimestamp":1740684909,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时35分，Biovie Inc.股票出现异动，股价大幅跳水5.59%。截至发稿，该股报1.35美元/股，成交量13.516万股，换手率0.73%，振幅4.99%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280335099895481d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280335099895481d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514168970","title":"Biovie Inc.盘中异动 早盘股价大跌5.21%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514168970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514168970?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:27","pubTimestamp":1740497247,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时27分，Biovie Inc.股票出现波动，股价急速下跌5.21%。截至发稿，该股报1.37美元/股，成交量12.8845万股，换手率0.70%，振幅6.24%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232728a2539489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232728a2539489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509011042","title":"Biovie Inc.盘中异动 快速下跌5.22%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509011042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509011042?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:52","pubTimestamp":1738860741,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时52分，Biovie Inc.股票出现异动，股价急速跳水5.22%。截至发稿，该股报1.91美元/股，成交量15.4829万股，换手率0.87%，振幅4.48%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005221961a2f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005221961a2f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509337662","title":"Biovie Inc.盘中异动 股价大涨5.11%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509337662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509337662?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:55","pubTimestamp":1738770932,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时55分，Biovie Inc.股票出现波动，股价快速上涨5.11%。截至发稿，该股报1.83美元/股，成交量24.158万股，换手率1.36%，振幅6.75%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523553296191842&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020523553296191842&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509989734","title":"Biovie Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509989734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509989734?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:01","pubTimestamp":1738695681,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时01分，Biovie Inc.股票出现异动，股价快速拉升5.31%。截至发稿，该股报1.69美元/股，成交量29.078万股，换手率1.64%，振幅6.87%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050301229618012a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502050301229618012a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149370","title":"Biovie Inc.盘中异动 股价大跌10.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149370?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593216,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Biovie Inc.股票出现异动，股价大幅下挫10.17%。截至发稿，该股报1.48美元/股，成交量10.9718万股，换手率0.62%，振幅5.32%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223336abc10786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223336abc10786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BIVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507548842","title":"Biovie Inc.盘中异动 早盘大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507548842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507548842?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:58","pubTimestamp":1738079904,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时58分，Biovie Inc.股票出现波动，股价大幅跳水5.34%。截至发稿，该股报1.69美元/股，成交量16.3541万股，换手率0.92%，振幅7.02%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282358249875758a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282358249875758a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506656302","title":"Biovie Inc.盘中异动 临近午盘快速下跌5.70%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506656302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506656302?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:43","pubTimestamp":1737996196,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时43分，Biovie Inc.股票出现异动，股价快速下跌5.70%。截至发稿，该股报1.82美元/股，成交量15.7208万股，换手率0.88%，振幅3.63%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004316a231861c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128004316a231861c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503234647","title":"Biovie Inc.盘中异动 早盘快速拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503234647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503234647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951606,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Biovie Inc.股票出现异动，股价大幅上涨5.59%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Exicure, Inc.、Allovir, Inc.、Cabaletta Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.53%、57.39%、35.56%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223326a222feaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223326a222feaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503944583","title":"Biovie Inc.盘中异动 早盘大幅跳水5.43%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503944583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503944583?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:36","pubTimestamp":1736778976,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时36分，Biovie Inc.股票出现波动，股价大幅下挫5.43%。截至发稿，该股报2.09美元/股，成交量3.2677万股，换手率0.18%，振幅1.36%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.99%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3453.00%、2120.42%、393.12%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、61.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223616aba9324f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223616aba9324f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501077698","title":"Biovie Inc.盘中异动 早盘股价大跌5.26%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501077698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501077698?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:50","pubTimestamp":1736347819,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时50分，Biovie Inc.股票出现异动，股价急速下跌5.26%。截至发稿，该股报2.34美元/股，成交量36.5795万股，换手率2.06%，振幅7.69%。Biovie Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225019aba35030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108225019aba35030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500648635","title":"Biovie Inc.盘中异动 股价大跌5.25%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500648635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500648635?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:17","pubTimestamp":1735665470,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时17分，Biovie Inc.股票出现异动，股价大幅下挫5.25%。截至发稿，该股报1.98美元/股，成交量27.8952万股，换手率1.57%，振幅7.13%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101011751ab99a0cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101011751ab99a0cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493766193","title":"Biovie Inc.盘中异动 股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493766193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493766193?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:44","pubTimestamp":1734965065,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时44分，Biovie Inc.股票出现异动，股价大幅拉升5.79%。截至发稿，该股报2.01美元/股，成交量5.8798万股，换手率0.33%，振幅5.79%。Biovie Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Biovie Inc.公司简介：BioVie Inc 是一家临床阶段公司，开发药物疗法来治疗慢性衰弱性疾病，包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223224425ab8e46e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223224425ab8e46e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BIVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioviepharma.com","stockEarnings":[{"period":"1week","weight":-0.141},{"period":"1month","weight":-0.0596},{"period":"3month","weight":-0.0946},{"period":"6month","weight":0.0635},{"period":"1year","weight":-0.1572},{"period":"ytd","weight":0.1552}],"compareEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1155},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioVie Inc.成立于2013年4月10日，是一家内华达州公司。该公司是一家临床阶段的公司，致力于开发创新药物疗法，以治疗慢性衰弱疾病，包括神经和神经退行性疾病以及肝脏疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.005325},{"month":2,"riseRate":0.5,"avgChangeRate":0.259645},{"month":3,"riseRate":0.625,"avgChangeRate":-0.036628},{"month":4,"riseRate":0.375,"avgChangeRate":0.025089},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.110348},{"month":6,"riseRate":0.555556,"avgChangeRate":0.426902},{"month":7,"riseRate":0.444444,"avgChangeRate":0.260814},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.199671},{"month":9,"riseRate":0.375,"avgChangeRate":-0.162595},{"month":10,"riseRate":0.375,"avgChangeRate":0.201324},{"month":11,"riseRate":0.5,"avgChangeRate":-0.005666},{"month":12,"riseRate":0.25,"avgChangeRate":-0.131533}],"exchange":"NASDAQ","name":"BioVie Inc","nameEN":"BioVie Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioVie Inc,BIVI,BioVie Inc股票,BioVie Inc股票老虎,BioVie Inc股票老虎国际,BioVie Inc行情,BioVie Inc股票行情,BioVie Inc股价,BioVie Inc股市,BioVie Inc股票价格,BioVie Inc股票交易,BioVie Inc股票购买,BioVie Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}